BRIEF-Regulus Therapeutics Reports Q3 Net Loss $0.04 Per Share
* REGULUS THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND RECENT UPDATES
* REGULUS THERAPEUTICS INC (RGLS) - QTRLY NET LOSS
* REGULUS THERAPEUTICS INC (RGLS) - QTRLY REVENUE UNDER STRATEGIC
ALLIANCES
* REGULUS THERAPEUTICS INC (RGLS) - AS OF